Kenneth Bender, PharmD, MA

A review of the research on eHealth and mHealth interventions for youth with HIV concludes these types of interventions should be scaled up and more widely implemented.

A review of tardive dyskinesia epidemiology implicates newer "atypical" antipsychotics as well as older neuroleptics.

A retrospective study showed a probability of maintaining HIV viral suppression of 98.2% at 48 weeks and 95.1% at 96 weeks, with the switch to the dolutegravir/lamivudine antiretroviral regimen.

Two studies examine whether users of daily oral PrEP would switch to a long-acting injection with interesting results.

The combined results of a recent meta-analysis and a new population-based study supports there being a significant association between asthma and ADHD.

Overweight and obesity in people with HIV are linked to behavioral factors and longer lives, not adverse effects of antiretroviral therapy, according to a new study.

A study of pediatric patients with asthma admitted to emergency departments has determined that while rhinovirus is the most prevalent infection, it is the non-rhinovirus pathogens that are associated with an increased absolute risk of treatment failure.

The ACAAI's new yardstick for pediatric asthma provides guidance on stepping-up asthma treatments to gain and maintain symptom control.

Canadian study finds patient's age is a modest factor in HIV viral rebound after suppression with treatment.

A systematic review and meta-analysis reveals differences between VMAT-2 inhibitors for tardive dyskinesia in absence of head-to-head clinical trials.

The CDC finds that substantial numbers of persons unaware of their HIV infection report missed opportunities for earlier diagnosis.

The FDA's approval of erenumab marked a milestone in migraine treatment, and although the calcitonin gene-related peptide inhibitor class is full of promise, it has overcome many pitfalls along the way.

First-line protease inhibitors posed different risks for cardiovascular disease in an international study of adverse events in HIV patients.

The FDA agreed to remove a boxed warning from inhalant combinations of corticosteroid and long-acting beta-agonist following research from a collaboration of pharmaceutical manufacturers.

Reports published by the CDC indicate that HIV screening is underutilized, and that providers often do not offer the test to patients who could benefit.

Companion studies of dupilumab find it safe and efficacious, as well as glucocorticoid-sparing in patients with moderate-to-severe asthma.

Trials of valbenazine for TD do not find that the treatment adds to cardiovascular disease risks associated with schizophrenia or the cardiovascular complications of antipsychotics.

Eligibility criteria for HIV pre-exposure prophylaxis (PrEP) based on behavioral markers does not capture all with biological markers for HIV risk.

Half of patients admitted to an emergency department for uncontrolled asthma had unknowingly emptied their bronchodilator inhaler, according to a recent study.

Obstructive sleep apnea could be the cause of fatigue in many people with HIV.

Though patients had a clinically meaningful increase in pre-bronchodilator FEV1, they did not evidence a significantly improved annualized asthma exacerbation rates compared with placebo.

The first study to explore long-term impact of AIDS activism finds posttraumatic stress responses concurrent with posttraumatic growth.

A trial of 2 different vitamin D supplementation methods found that one of them is capable of reducing recurrent wheezing in preterm infants.

Individualized holistic, evidence-based medicine will be accessible to more patients in New York beginning in June 2018, when the 2-year-old Integrative Health and Wellbeing program expands from its original site.

An association between antibiotic treatment in infancy and development of atopic asthma in childhood suggests an immune-mediated effect.

Review finds PrEP can prevent HIV when those at-risk have access, and are adherent to the treatment.

One inhalation product can be effective as a single maintenance and reliever therapy for asthma.

Adding an anti-muscarinic to inhaled corticosteroid reduces asthma exacerbations, but possibly not more than other combinations.

Antiretroviral drug levels were monitored to determine whether they are useful in guiding regimens for treatment-resistant HIV-AIDS.

Modeling predicts cost-effective approach to HIV drug resistance in low-resource, highly afflicted sub-Saharan Africa.